Efficacy and safety of orally/sublingually, intranasally and intraperitoneally administered recombinant murine interferon in the treatment of murine encephalomyocarditis virus.

G. Sonnenveld; H. Tovey; H. Schellekens; K.S. Kinney; T. Belay; D.S. Morton; C.E. Austin; M. Reitman; T.A. Fong; H.S. Vaughan

Efficacy and safety of orally/sublingually, intranasally and intraperitoneally administered recombinant murine interferon in the treatment of murine encephalomyocarditis virus.

G. Sonnenveld
, H. Tovey
, H. Schellekens
, K.S. Kinney
, T. Belay
, D.S. Morton
, C.E. Austin
, M. Reitman
, T.A. Fong
, H.S. Vaughan

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	539-545
Number of pages	7
Journal	Journal of Interferon and Cytokine Research
Volume	21
Issue number	7
Publication status	Published - 2001

Cite this

Sonnenveld, G., Tovey, H., Schellekens, H., Kinney, K. S., Belay, T., Morton, D. S., Austin, C. E., Reitman, M., Fong, T. A., & Vaughan, H. S. (2001). Efficacy and safety of orally/sublingually, intranasally and intraperitoneally administered recombinant murine interferon in the treatment of murine encephalomyocarditis virus. Journal of Interferon and Cytokine Research, 21(7), 539-545.

@article{6cd42b21dc8d473aba24dbd4433b35de,

title = "Efficacy and safety of orally/sublingually, intranasally and intraperitoneally administered recombinant murine interferon in the treatment of murine encephalomyocarditis virus.",

author = "G. Sonnenveld and H. Tovey and H. Schellekens and K.S. Kinney and T. Belay and D.S. Morton and C.E. Austin and M. Reitman and T.A. Fong and H.S. Vaughan",

year = "2001",

language = "Undefined/Unknown",

volume = "21",

pages = "539--545",

journal = "Journal of Interferon and Cytokine Research",

issn = "1079-9907",

publisher = "SAGE",

number = "7",

}

Sonnenveld, G, Tovey, H, Schellekens, H, Kinney, KS, Belay, T, Morton, DS, Austin, CE, Reitman, M, Fong, TA & Vaughan, HS 2001, 'Efficacy and safety of orally/sublingually, intranasally and intraperitoneally administered recombinant murine interferon in the treatment of murine encephalomyocarditis virus.', Journal of Interferon and Cytokine Research, vol. 21, no. 7, pp. 539-545.

Efficacy and safety of orally/sublingually, intranasally and intraperitoneally administered recombinant murine interferon in the treatment of murine encephalomyocarditis virus. / Sonnenveld, G.; Tovey, H.; Schellekens, H. et al.
In: Journal of Interferon and Cytokine Research, Vol. 21, No. 7, 2001, p. 539-545.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Efficacy and safety of orally/sublingually, intranasally and intraperitoneally administered recombinant murine interferon in the treatment of murine encephalomyocarditis virus.

AU - Sonnenveld, G.

AU - Tovey, H.

AU - Schellekens, H.

AU - Kinney, K.S.

AU - Belay, T.

AU - Morton, D.S.

AU - Austin, C.E.

AU - Reitman, M.

AU - Fong, T.A.

AU - Vaughan, H.S.

PY - 2001

Y1 - 2001

M3 - Article

SN - 1079-9907

VL - 21

SP - 539

EP - 545

JO - Journal of Interferon and Cytokine Research

JF - Journal of Interferon and Cytokine Research

IS - 7

ER -